Maria-Paraskevi Moschofidou, has been Graduated from A.T.E.I Thessaloniki Faculty of Supply Chain Management, with the specialties including Economics, Project management, Total Quality Management, International Law, with emphasis on Business Management, Marketing,Labor psychology. Later on she obtained her post-graduation from Open University of Cyprus Faculty of Health Policy and Planning and also from Swiss Tropical and Public Health Institute, Faculty of Public Health, with subjects Health care strategic planning and evaluation, Human resources management and leadership, Health policy and politics, Introduction to epidemiology and research methodology, Information technology and healthcare systems and then started working at privite clinic in Lausanne where she has continued her research.

The HRM department will dictate the success or failure of an organization. Many organizations have adopted different HRM practices in an effort to provide the best to their clients. The provision of Medicare is also in line with efficient HRM practices. The workforce, insurance services, access to Healthcare, training for employees, the connection between public health and healthcare providers are some of the issues identified for having implications in the human resources. Most of the problems arising from the stated issues have impacted the delivery of healthcare and its efficiency. In the greece and Switzerland, the practices adopted are different, their approaches to the stated issues are discussed at length. The problems arising from the HRM department in Swiss and some of the proposed solutions are indicated.

Specialist in pharmacoepidemiology. Researcher, Autonomous University of Nayarit, Academic Unit of Biological Chemistry Sciences And Pharmaceuticals

Mexico is experiencing a crisis in the health sector, both public and private. The public sector has excess of beneficiaries, lack of infrastructure and human personnel; Making this alternative an odyssey, where some patients are fortunate to be attended at the time, but others not, creating an epidemiologically risky asymmetry.\r\nEven with the financial crisis facing Mexicans, people opt for private care, the great limitation in this regard is the cost of private health care for each person.\r\nAnalyzing the price of medical care in our country, the national unit cost per consultation of private family care has an average cost of $ 35 dollars; Consultation with a specialist can reach up to $ 55 dollars.\r\nBy contextualizing the problem and as an example, we could mention that a pathology of bacterial etiology that requires an antibiotic to fight it, it costs between $ 22 and $ 55 dollars, with a total between medical consultation and pharmacological treatment up to $ 110 dollars approximately.\r\nOn the other hand, from a social economic perspective, we observe that, of the country\'s 119 million inhabitants, only 50.7 million are economically active, that is, less than half the population; Of this fraction, 67.25% earn less than $ 255 dollars per month, and in many cases, only one person contributes money to family expenses.\r\nThen our question is, Who can really have access to health in Mexico?\r\nDespite this disconcerting scenario, there are measures that can be applied from the medical consultation to the pharmacological dispensation, which could reduce the impact on the patient\'s family economy. This implies respecting the General Health Law on medicines and the Mexican pharmaceutical policy by all professionals involved in the health - disease cycle.\r\n\r\n